Format

Send to

Choose Destination
JAMA Ophthalmol. 2014 Jul;132(7):906. doi: 10.1001/jamaophthalmol.2014.1805.

Indications and limitations of vismodegib for basal cell carcinoma--reply.

Author information

1
Department of Ophthalmology and Vision Sciences, University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada.
2
Division of Oculofacial Plastic and Orbital Surgery, California Pacific Medical Center, Oakland.
3
Division of Ophthalmic Plastic, Reconstructive, and Orbital Surgery, California Pacific Medical Center, Oakland.
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center